Engineers Gate Manager’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,572
Closed -$27.8K 2271
2025
Q4
$27.8K Sell
13,572
-3,375
-20% -$9.74K ﹤0.01% 2014
2025
Q3
$58.8K Buy
+16,947
New +$47.3K ﹤0.01% 2048
2025
Q1
Sell
-79,159
Closed -$101K 2253
2024
Q4
$101K Buy
79,159
+65,354
+473% +$167K ﹤0.01% 1996
2024
Q3
$47.1K Sell
13,805
-93,548
-87% -$407K ﹤0.01% 1986
2024
Q2
$501K Buy
107,353
+19,364
+22% +$109K 0.01% 1219
2024
Q1
$653K Sell
87,989
-3,591
-4% -$29.8K 0.02% 1055
2023
Q4
$928K Buy
91,580
+33,834
+59% +$297K 0.03% 837
2023
Q3
$450K Sell
57,746
-28,735
-33% -$246K 0.02% 1101
2023
Q2
$712K Buy
+86,481
New +$753K 0.03% 866
2022
Q4
Sell
-43,002
Closed -$526K 1761
2022
Q3
$526K Buy
43,002
+14,741
+52% +$230K 0.03% 778
2022
Q2
$334K Buy
28,261
+1,713
+6% +$23K 0.01% 1342
2022
Q1
$505K Buy
26,548
+10,275
+63% +$191K 0.02% 1060
2021
Q4
$432K Sell
16,273
-8,397
-34% -$289K 0.02% 1161
2021
Q3
$1.01M Buy
+24,670
New +$1.35M 0.06% 489
2021
Q2
Sell
-19,860
Closed -$834K 1708
2021
Q1
$834K Buy
+19,860
New +$1.13M 0.04% 668
2020
Q4
Sell
-17,544
Closed -$492K 1765
2020
Q3
$492K Buy
17,544
+2,736
+18% +$89.1K 0.02% 1004
2020
Q2
$438K Buy
14,808
+326
+2% +$8.52K 0.02% 1015
2020
Q1
$287K Sell
14,482
-5,718
-28% -$144K 0.02% 1065
2019
Q4
$598K Buy
20,200
+8,976
+80% +$224K 0.03% 898
2019
Q3
$255K Buy
+11,224
New +$278K 0.01% 1080

Other funds holding EDIT

Engineers Gate Manager's EDIT Position: Q1 2026 in Review

Engineers Gate Manager sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 13,572 shares — an estimated $27.8K sold.

Engineers Gate Manager first reported a position in EDIT in Q3 2019 and held it in 20 quarters. The position peaked at $1.01M in Q3 2021. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Engineers Gate Manager reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 13,572 Editas Medicine shares in Q1 2026, an estimated $27.8K.
  • Engineers Gate Manager first reported a position in Editas Medicine in Q3 2019 and held it in 20 quarters.
  • Engineers Gate Manager's Editas Medicine position peaked at $1.01M in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.